Cystic Fibrosis (CF) Therapeutics Global Market Research Report 2024: Burgeoning Emphasis on Personalized Medicine and Targeted Therapies - Long-term Forecasts to 2028 and 2033
June 27, 2024 07:40 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis (CF) Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The cystic fibrosis (cf)...
Global Cystic Fibrosis Market Report 2024: Growth Amid Rising Prevalence and Innovative Therapeutic Developments - Forecasts to 2029
June 21, 2024 06:58 ET
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. Emerging Therapeutics and...
Cystic Fibrosis Therapeutics Global Strategic Business Report 2023-2030 Featuring Key Players - AbbVie, Galapagos, Genentech, Gilead Sciences, Novartis, and Vertex Pharmaceuticals
June 13, 2024 05:42 ET
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Cystic Fibrosis Industry Report 2024: Epidemiology, Drug Sales, Trends, and Forecasts to 2034 Across the 7MM
June 12, 2024 11:22 ET
|
Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034" report has been added to ...
PULMOZYME (Dornase Alfa) Drug Insights and Market Forecasts, 2019-2022 and 2023-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom and Japan
December 14, 2023 10:23 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "PULMOZYME Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Cystic Fibrosis (CF) Therapeutics Global Research Report 2023: Market to Reach $10.11 Billion in 2027 - Long-term Forecast to 2032
November 29, 2023 10:33 ET
|
Research and Markets
Dublin, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis (CF) Therapeutics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global cystic fibrosis...
Global Cystic Fibrosis Treatment Market Report 2023: Featuring AbbVie, Chiesi Farmaceutici, Novartis, Pharmaxis, AstraZeneca & More
May 24, 2023 06:33 ET
|
Research and Markets
Dublin, May 24, 2023 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global market...
Global Cystic Fibrosis Therapeutics Markets, Trends, & Forecasts Report 2023-2028: Inhale Market will Capture Maximum Share of the $10+ Billion Market
March 03, 2023 04:58 ET
|
Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Company Analysis" report has been...
Global Cystic Fibrosis Market to Reach $37.04 Billion by 2030: Players Include Roche, Nestle Health Science, AbbVie, Viatris and Horizon Therapeutic
February 10, 2023 10:08 ET
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Market Share, Size, Trends By Drug Class, Route of Administration, By Distribution Channel, By Region, Segment Forecast, 2022 - 2030"...
Global Cystic Fibrosis Market Report 2022-2030 - Expanding Therapeutic Options is Expected to Drive Market Growth
August 03, 2022 08:03 ET
|
Research and Markets
Dublin, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,...